Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP321079.RACP8Q6W3W3QxUFptIGQicl2E8RUvaBFMuwPReF1H0VDk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP321079.RACP8Q6W3W3QxUFptIGQicl2E8RUvaBFMuwPReF1H0VDk130_assertion type Assertion NP321079.RACP8Q6W3W3QxUFptIGQicl2E8RUvaBFMuwPReF1H0VDk130_head.
- NP321079.RACP8Q6W3W3QxUFptIGQicl2E8RUvaBFMuwPReF1H0VDk130_assertion description "[These results not only highlight the potential of a synergistic drug combination of allosteric PARP inhibitors with DNA-damaging agents in genomically unstable cancer cells (regardless of homologous recombination status), but also signify important applications of selective PARP-1 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321079.RACP8Q6W3W3QxUFptIGQicl2E8RUvaBFMuwPReF1H0VDk130_provenance.
- NP321079.RACP8Q6W3W3QxUFptIGQicl2E8RUvaBFMuwPReF1H0VDk130_assertion evidence source_evidence_literature NP321079.RACP8Q6W3W3QxUFptIGQicl2E8RUvaBFMuwPReF1H0VDk130_provenance.
- NP321079.RACP8Q6W3W3QxUFptIGQicl2E8RUvaBFMuwPReF1H0VDk130_assertion SIO_000772 24189460 NP321079.RACP8Q6W3W3QxUFptIGQicl2E8RUvaBFMuwPReF1H0VDk130_provenance.
- NP321079.RACP8Q6W3W3QxUFptIGQicl2E8RUvaBFMuwPReF1H0VDk130_assertion wasDerivedFrom befree-20150227 NP321079.RACP8Q6W3W3QxUFptIGQicl2E8RUvaBFMuwPReF1H0VDk130_provenance.
- NP321079.RACP8Q6W3W3QxUFptIGQicl2E8RUvaBFMuwPReF1H0VDk130_assertion wasGeneratedBy ECO_0000203 NP321079.RACP8Q6W3W3QxUFptIGQicl2E8RUvaBFMuwPReF1H0VDk130_provenance.